![[img]](https://epub.uni-regensburg.de/style/images/fileicons/application_pdf.png) | Lizenz: Creative Commons Namensnennung 4.0 International Early View (5MB) |
- URN zum Zitieren dieses Dokuments:
- urn:nbn:de:bvb:355-epub-775013
- DOI zum Zitieren dieses Dokuments:
- 10.5283/epub.77501
Teubner, Jan P. ; Tümen, Deniz ; Kandulski, Arne ; Heumann, Philipp ; Mester, Patricia ; Aschenbrenner, Elisabeth ; Pollinger, Kirstin ; Gunckel, Manuela ; Volz, Barbara ; Hein, Tobias ; Beltzig, Paul L. ; Tengler, Luisa ; Voll, Florian ; Kreutz, Marina ; Kunst, Claudia ; Nicolay, Jan P. ; Müller, Martina ; Gülow, Karsten 
Diese Publikation ist Teil des DEAL-Vertrags mit Wiley.
Zusammenfassung
Constitutive activation of the nuclear factor kappa-light-chain-enhancer of activated B cells (NF-κB) pathway is a hallmark of many lymphocyte-associated cancers, including cutaneous T-cell lymphoma (CTCL) and its leukemic variant, the Sézary syndrome. Dimethyl fumarate (DMF) has been identified as a promising NF-κB-targeted therapy and has shown positive outcomes in a phase II clinical trial ...
Nur für Besitzer und Autoren: Kontrollseite des Eintrags
Downloadstatistik